Search Within

Ahmet Dogan

  1. "Lymphoma"
Formats
  1. Meeting Abstract (84)
  2. Journal Article (58)
  3. Research Letter (9)
  4. Guidelines (5)
  5. Book Section (2)
  6. Correspondence (2)
  7. Review (1)
Groups
  1. Center for Hematologic Malignancies (161)
  2. Department of Medicine (161)
  3. Department of Pathology and Laboratory Medicine (161)
  4. Hematologic Malignancies, Division of (161)
  5. Lymphoma (161)
  6. Population Sciences Research Program (100)

More Groups

People
  1. Steven Horwitz (92)
  2. Andrew Zelenetz (74)
  3. Alison Moskowitz (69)
  4. Anita Kumar (55)
  5. Maria Palomba (55)
  6. Ariela Noy (48)

More People

Years
  1. 2025 (4)
  2. 2024 (8)
  3. 2023 (21)
  4. 2022 (14)
  5. 2021 (17)
  6. 2020 (25)

More Years

Publications
  1. Blood (62)
  2. Hematological Oncology (12)
  3. Blood Advances (10)
  4. Journal of Clinical Oncology (9)
  5. Blood Cancer Journal (7)
  6. Laboratory Investigation (6)

More Publications

Publishers
  1. American Society of Hematology (72)
  2. Nature Publishing Group (19)
  3. Wiley Blackwell (18)
  4. American Society of Clinical Oncology (10)
  5. Ferrata Storti Foundation (5)
  6. Nature Research (5)

More Publishers

Results (161)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Angioimmunoblastic T-cell lymphoma
    Journal Article

    Yabe, M.; Dogan, A.; Horwitz, S. M.; Moskowitz, A. J.
    Cancer Treatment and Research (2019)

    Fulltext@MSK | Save
  • Clinical responses and pharmacokinetics of MCARH171, a human-derived BCMA targeted CAR T cell therapy in relapsed/refractory multiple myeloma: Final results of a phase I clinical trial
    Meeting Abstract

    Mailankody, S.; Ghosh, A.; Staehr, M.; Purdon, T. J.; Roshal, M.; Halton, E.; Diamonte, C.; Pineda, J.; Anant, P.; Bernal, Y.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • The combination of duvelisib, a PI3K-δ,γ inhibitor, and romidepsin is highly active in relapsed/refractory peripheral T-cell lymphoma with low rates of transaminitis: Results of parallel multicenter, phase 1 combination studies with expansion cohorts
    Meeting Abstract

    Horwitz, S. M.; Moskowitz, A. J.; Jacobsen, E. D.; Mehta-Shah, N.; Khodadoust, M. S.; Fisher, D. C.; Myskowski, P.; Wang, E. B. K.; Tawa, M.; Davey, T.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Pilot trial of ibrutinib in patients with relapsed or refractory T-cell lymphoma
    Journal Article

    Kumar, A.; Vardhana, S.; Moskowitz, A. J.; Porcu, P.; Dogan, A.; Dubovsky, J. A.; Matasar, M. J.; Zhang, Z.; Younes, A.; Horwitz, S. M.
    Blood Advances (2018)

    Fulltext@MSK | Save
  • Durable responses observed with JAK inhibition in T-cell lymphomas
    Meeting Abstract

    Moskowitz, A. J.; Jacobsen, E.; Ruan, J.; Schatz, J. H.; Obadi, O.; Motylinski, K.; Jarjies, C.; Galasso, N.; Hancock, H.; Davey, T.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Initial results of a phase II study of sequential chemotherapy and lenalidomide followed by rituximab and lenalidomide maintenance for untreated mantle cell lymphoma
    Meeting Abstract

    Kumar, A.; Zelenetz, A. D.; Batlevi, C. L.; Caron, P.; Dogan, A.; Drullinsky, P.; Gerecitano, J.; Hamilton, A.; Hamlin, P. A.; Laraque, L.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Romidepsin activity in T follicular helper(TFH)-phenotype PTCL versus non TFH treated on the same clinical trials
    Meeting Abstract

    Ghione, P.; Ozkaya, N.; Faruque, P.; Mehta-Shah, N.; Lunning, M. A.; Ruan, J.; Galasso, N.; Moskowitz, A. J.; Dogan, A.; Horwitz, S. M.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • T-cell receptor-δ expression and γδ+ T-cell infiltrates in primary cutaneous γδ T-cell lymphoma and other cutaneous T-cell lymphoproliferative disorders
    Journal Article

    Pulitzer, M.; Geller, S.; Kumar, E.; Frosina, D.; Moskowitz, A.; Horwitz, S.; Myskowski, P.; Kheterpal, M.; Chan, A.; Dogan, A.; more...
    Histopathology (2018)

    Fulltext@MSK | Save
  • Peripheral T-cell lymphoma – Are we making progress?
    Journal Article

    Khan, N.; Ozkaya, N.; Moskowitz, A.; Dogan, A.; Horwitz, S.
    Best Practice and Research: Clinical Haematology (2018)

    Fulltext@MSK | Save
  • Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models
    Journal Article

    Ng, S. Y.; Yoshida, N.; Christie, A. L.; Ghandi, M.; Dharia, N. V.; Dempster, J.; Murakami, M.; Shigemori, K.; Morrow, S. N.; Van Scoyk, A.; more...
    Nature Communications (2018)

    Fulltext@MSK | Save